Onconic Therapeutics Inc. (KOSDAQ:476060)
South Korea · Delayed Price · Currency is KRW 26,900
-1,000 (-3.58%)
Jul 21, 2025, 9:50 AM KST
Onconic Therapeutics Market Cap
Onconic Therapeutics has a market cap or net worth of 306.96 billion as of July 18, 2025.
Market Cap
306.96B
Enterprise Value
262.75B
Revenue
22.69B
Ranking
n/a
PE Ratio
n/a
Stock Price
26,900.00
Market Cap Chart
Since December 19, 2024, Onconic Therapeutics's market cap has increased from 186.91B to 306.96B, an increase of 64.23%. That is a compound annual growth rate of 135.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 18, 2025 | 306.96B | 73.88% |
| Dec 30, 2024 | 176.54B | -5.55% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 74.80T |
| Celltrion | 39.82T |
| ALTEOGEN | 26.19T |
| Yuhan | 9,866.54B |
| SK Biopharmaceuticals | 8,066.26B |
| HLB Co., Ltd. | 6,939.04B |
| Peptron | 6,861.07B |
| PharmaResearch | 5,890.93B |